US 9,539,218 B2
Prevention and treatment of thromboembolic disordersGeneral
US 9,539,218 B2
Prevention and treatment of thromboembolic disorders
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Sreeni Padmanabhan
Art Unit:
1627 Organic Chemistry
Inventors:
Frank Misselwitz; Dagmar Kubitza; Son-Mi Park; Klaus Wehling
Assignee:
Priority:
01/31/05
Filed:
01/19/06
Granted:
01/10/17
Expiration:
02/17/34
Abstract
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
Cooperative Patent Classification (CPC)
A61A61P7/00A61K31/5377A61P